MYR Pharmaceuticals — Treatment of HBV & HDV Infections
Career opportunities — Join our team! Privacy Policy
MYR Pharmaceuticals
From HDV control to HBV cure
Myrcludex B has been tested in a total of six clinical trials (four completed and two ongoing) that include 239 human subjects – healthy volunteers and Hepatitis B and D patients. More...
